Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04155190
Title An Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCC
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors PellePharm, Inc.
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.